Startup Directory
Boston Startups
Discover startups in Boston with funding rounds, founder profiles, sector clusters, hiring signals, and connected country or market news coverage.
Research Brief
How to read this Boston startup list
This page organizes startups in Boston by funding, founder, category, hiring, and company momentum signals. The goal is to help readers move from a broad location search into specific company profiles, founder context, market categories, and funding-stage comparisons. Pages with stronger data depth remain selected for deeper public coverage; lower-volume pages stay live for readers as lightweight discovery routes until the market coverage improves.
Startup market context for Boston
Boston startup discovery is most useful when geography is connected to sector density, hiring motion, investor access, and recent funding. A city or country page should not only list companies; it should explain where founder activity is forming, which sectors are attracting capital, and which companies are building repeatable traction. This directory currently tracks 16 indexed companies for this location context.
CFCommonwealth Fusion
Building the path to clean, carbon-free, limitless energy Sustainability Renewable Energies
Last round: Series B Khosla Ventures, $2B Series B in 2021
RTROME Therapeutics
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome. Biotech Healthcare Pharmaceuticals
Last round: Series B Andreessen Horowitz, $50M Series B in 2021, $70M valuation
SMScipher Medicine
Scipher Medicine develops a healthcare platform designed to determine which drug will work best for each patient. Healthcare Biotech
Last round: Series D Khosla Ventures, $110M Series D in 2022
Biofourmis
Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics. Healthcare Biotech
Last round: Series C Sequoia, $100M Series C in 2020, $700M valuation
Silk
Silks optimizes the cloud, allowing organizations to get 10x the performance while spending 30% less SaaS Enterprise Software
Last round: Series B Sequoia, $55M Series B in 2021
ZHZus Health
Zus empowers an entirely new wave of healthcare builders to create technologies and services without the usual blockers Healthcare Medical Software
Last round: Series A Andreessen Horowitz, $40M Series A in 2023
DHDevoted Health
Devoted Health is a healthcare company serving seniors and giving them a health care plan with personal guides and world-class technology. Healthcare Elder Care
Last round: Series D Andreessen Horowitz, $362M Series D in 2021, $1.1B valuation
SDStarburst Data
Starburst Data is a data access and analytics company developing an SQL query engine. Software Analytics Data Science
Last round: Series D Andreessen Horowitz, $250M Series D in 2022, $3.4B valuation
AAsimov
Asimov builds tools to program living cells. Biotech
Last round: Series B Andreessen Horowitz, $175M Series B in 2023
eGenesis
eGenesis is a life sciences company focused on development and commercialization of engineered organisms for the benefit of human health. Biotech
Last round: Series C Khosla Ventures, $125M Series C in 2021, $99M valuation
Digital.ai
Leading provider of software delivery automation for the enterprise. Enterprise Software Developer Tools
Last round: Series B Accel, $122M Series B in 2018
Dyno Therapeutics
Dyno Therapeutics uses artificial intelligence for gene therapy. Healthcare Biotech Artificial Intelligence
Last round: Series A Andreessen Horowitz, $100M Series A in 2021
CTCAMP4 Therapeutics
BioTech. Solving how genes are controlled to drive the efficient development of treatments. Biotech
Last round: Series B Andreessen Horowitz, $100M Series B in 2022
Devo
Devo is a cybersecurity company that provides cloud-native logging and security analytics for organizations. Cybersecurity Enterprise Software
Last round: Series F Bessemer, $100M Series F in 2022, $2.0B valuation
Fractyl Labs
Developing an Innovative Endoscopic Outpatient Procedure to Improve Glycemic Control for Type 2 Diabetes Healthcare Medical Devices
Last round: Series F Bessemer, $100M Series F in 2021
EEmulate
Emulate is focused on commercializing Organs-on-Chips. Healthcare Biotech
Last round: Series E Founders Fund, $82M Series E in 2021
Related Startup Pages
Internal Research Paths
Continue research from this page
FAQ
Questions about Boston startups
What is this Boston startup page?
It is a 100Xfounder directory page for startups in Boston, combining company profiles, founder context, funding signals, hiring indicators, and internal links into related market pages. 16 companies are currently included in this view.
How are startups in Boston selected?
The page uses structured 100Xfounder company and founder data, then groups profiles by location. Ordering favors stronger funding, verified company context, founder detail, hiring signals, and useful internal research paths.
How complete is this market page?
This page currently has enough company depth for a full public market brief and inclusion in discovery feeds.
Where should I go next after this Boston list?
Use related founder profiles, company pages, funding-round pages, country hubs, startup jobs, salary-equity pages, and newsroom coverage to understand the broader market context around these companies.
Connected Pillar Routes
Continue discovery through country, industry, stage, funding, and newsroom hubs.